59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Martinez-Sobrido, Luis
Funded by
University of Texas Health Science Center at San Antonio
Collaborating Institutions
University of Texas Health Science Center San Antonio
We propose to investigate SARS-CoV-2 and identify key molecular interfaces in RSP complex for their immunogenic disruption. Additionally, we will conduct in vitro and in vivo testing of peptides for immunogenic molecular disruption.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Jonathan Bohmann
Funded by
U.S. Department of Defense, U.S. Army Medical Research Acquisition Activity
Collaborating Institutions
U.S. Army Medical Research Institute of Infectious Diseases
Texas Biomedical Research Institute
Walter Reed Army Institute of Research
Using Department of Defense supercomputers, Southwest Research Institute is virtually screening millions of drug compounds to search for and test possible treatment options for the novel coronavirus 2019. The Henry M. Jackson Foundation for the Advancement of Military Medicine has awarded SwRI a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Joe McDonough
Funded by
USAA and the USAA Foundation
Collaborating Institutions
Vaccine Development Center of San Antonio
San Antonio Partnership for Precision Therapeutics
The San Antonio Partnership for Precision Therapeutics (SAPPT) along with the Vaccine Development Center of San Antonio (VDCOSA) received a $1 million donation for critical COVID-19 medical research and equipment.
USAA and The USAA Foundation, Inc. officials announced the donation as part of an over $6 million gift benefiting local organizations and military families affected by the coronavirus pandemic.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
San Antonio Partnership for Precision Therapeutics
The major goal of this study is to develop a vaccine against COVID-19 by creating a recombinant Francisella bacterium that expresses SARS-CoV-2 spike protein.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Schlesinger, Larry S
Funded by
National Institutes of Health
The major goal is to increase primate holding capacity for the P51 base grant.
